160 related articles for article (PubMed ID: 25078571)
1. Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer.
Arias F; Chicata V; García-Velloso MJ; Asín G; Uzcanga M; Eito C; Quilez I; Viudez A; Saenz J; Hernández I; Caicedo C; Errasti M; Barrado M; García-Bragado F
Clin Transl Oncol; 2015 Feb; 17(2):139-44. PubMed ID: 25078571
[TBL] [Abstract][Full Text] [Related]
2. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
[TBL] [Abstract][Full Text] [Related]
3. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
[TBL] [Abstract][Full Text] [Related]
4.
Pedraza S; Ruiz-Alonso A; Hernández-Martínez AC; Cabello E; Lora D; Pérez-Regadera JF
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):154-159. PubMed ID: 30655026
[TBL] [Abstract][Full Text] [Related]
5. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
8. The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Haerle SK; Schmid DT; Ahmad N; Hany TF; Stoeckli SJ
Oral Oncol; 2011 Jul; 47(7):653-9. PubMed ID: 21658990
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
[TBL] [Abstract][Full Text] [Related]
10. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
11. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
12. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
Moeller BJ; Rana V; Cannon BA; Williams MD; Sturgis EM; Ginsberg LE; Macapinlac HA; Lee JJ; Ang KK; Chao KS; Chronowski GM; Frank SJ; Morrison WH; Rosenthal DI; Weber RS; Garden AS; Lippman SM; Schwartz DL
J Clin Oncol; 2009 May; 27(15):2509-15. PubMed ID: 19332725
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL
J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
[TBL] [Abstract][Full Text] [Related]
14. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
15. Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
Huang YT; Ravi Kumar AS
Nucl Med Commun; 2012 May; 33(5):503-8. PubMed ID: 22262244
[TBL] [Abstract][Full Text] [Related]
16. 18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.
Sheikhbahaei S; Marcus C; Subramaniam RM
PET Clin; 2015 Apr; 10(2):125-45. PubMed ID: 25829083
[TBL] [Abstract][Full Text] [Related]
17. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
[TBL] [Abstract][Full Text] [Related]
19. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF
Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
Teknos TN; Rosenthal EL; Lee D; Taylor R; Marn CS
Head Neck; 2001 Dec; 23(12):1056-60. PubMed ID: 11774391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
